The trademark CELEXION was filed by Celexion, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on May 17, 2011, and received one opposition filed on August 17, 2011 by McKesson Europe AG on Likelihood of confusion. the opponent was represented by LICHTENSTEIN & KÖRNER RECHTSANWÄLTE PARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued August 17, 2011
The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).
The renewal of the trademark was recorded by the office on January 14, 2022.
of the trademark registration was recorded on January 14, 2022. Change of name and professional address of the trademark registration was recorded on July 13, 2014. Change of name and professional address of the trademark registration was recorded on November 3, 2015. Appointment and Replacement of representative of the trademark registration was recorded on November 11, 2019. Change of name and professional address of the trademark registration was recorded on October 6, 2020.
Goods And Services
The mark was filed in class 1 with following description of goods:
Biochemicals, namely, polypeptides for in vitro research use
Biomedical compounds, namely, peptide substrates used in analysing and detecting certain toxins for clinical or medical laboratory use
Chemicals, namely, peptides and proteins for use in the manufacture of pharmaceuticals and chemical intermediates or for use in scientific and medical research, peptides or proteins for laboratory or research use, namely, for use in drug discovery, generation, and screening
All the aforementioned goods in this class not for sale to or by pharmacies.
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations, namely, peptides and proteins for use in the prevention, diagnosis and treatment of cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders, and reproductive disorders
Chemicals, namely, peptides and proteins for medical diagnostic purposes
All the aforementioned goods in this class not for sale to pharmacies and individual consumers.
The mark was filed in class 42 with following description of goods:
Drug discovery services
Conducting early evaluations in the field of new pharmaceuticals
Development of pharmaceutical preparations and medicines by screening of chemicals, peptides, polypeptides and proteins
Scientific pharmaceutical research services
Medical research services, namely, generating and displaying novel polypeptides for therapeutic and screening purposes.